http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Recent Progress in Waste Treatment Technology for Pyroprocessing at KAERI
Geun-Il Park,Min Ku Jeon,Jung-Hoon Choi,Ki-Rak Lee,Seung Youb Han,In Tae Kim,Yung-Zun Cho,Hwan-Seo Park 한국방사성폐기물학회 2019 방사성폐기물학회지 Vol.17 No.3
사용후핵연료의 효율적 관리를 위하여 한국원자력연구원에서 수행 중인 파이로 공정으로부터 발생되는 폐기물 처리기술에 대한 최근 연구동향을 종합적으로 고찰하였다. 파이로 폐기물 처리기술은 처분 대상 폐기물의 감용 및 포장, 저장과 최종 처분에 적합한 고화체 제조를 목표로 하고 있다. 한국원자력연구원에서 수행 중인 파이로 폐기물 처리 기술개발 접근 방향은 공정 흐름으로부터 발생한 폐기물내 주요 핵종들을 분리하고 회수한 물질 등을 재사용함으로서 폐기물 발생량을 최소로 하며 동시에 분리한 핵종을 별도로 고화처리하는 것이다. 폐기물 처리 주요 기술 특성은 먼저 전해환원용 원료물질 제조를 위하여 전처리 고온 열처리 공정을 사용하며, LiCl 과 LiCl-KCl 염으로부터 핵종을 분리하고 회수염의 재사용 및 핵종 함유량을 증대시킨 최종 고화체 제조 기술을 개발하는 것이다. 따라서 실험실 규모 실험 결과를 토대로 최근에는 공정 용량 증대를 위한 자료 확보를 목적으로 공학규모 시험을 수행 중에 있다. This study comprehensively addresses recent progress at KAERI in waste treatment technology to cope with waste produced by pyroprocessing, which is used to effectively manage spent fuel. The goal of pyroprocessing waste treatment is to reduce final waste volume, fabricate durable waste forms suitable for disposal, and ensure safe packaging and storage. KAERI employs grouping of fission products recovered from process streams and immobilizes them in separate waste forms, resulting in product recycling and waste volume minimization. Novel aspects of KAERI approach include high temperature treatment of spent oxide fuel for the fabrication of feed materials for the oxide reduction process, and fission product concentration or separation from LiCl or LiCl-KCl salt streams for salt recycling and higher fission-product loading in the final waste form. Based on laboratory-scale tests, an engineering-scale process test is in progress to obtain information on the performance of scale-up processes at KAERI.
EUTECTIC(LiCl-KCl) WASTE SALT TREATMENT BY SEQUENCIAL SEPARATION PROCESS
Cho, Yung-Zun,Lee, Tae-Kyo,Choi, Jung-Hun,Eun, Hee-Chul,Park, Hwan-Seo,Park, Geun-Il Korean Nuclear Society 2013 Nuclear Engineering and Technology Vol.45 No.5
The sequential separation process, composed of an oxygen sparging process for separating lanthanides and a zone freezing process for separating Group I and II fission products, was evaluated and tested with a surrogate eutectic waste salt generated from pyroprocessing of used metal nuclear fuel. During the oxygen sparging process, the used lanthanide chlorides (Y, Ce, Pr and Nd) were converted into their sat-insoluble precipitates, over 99.5% at $800^{\circ}C$; however, Group I (Cs) and II (Sr) chlorides were not converted but remained within the eutectic salt bed. In the next process, zone freezing, both precipitation of lanthanide precipitates and concentration of Group I/II elements were preformed. The separation efficiency of Cs and Sr increased with a decrease in the crucible moving speed, and there was little effect of crucible moving speed on the separation efficiency of Cs and Sr in the range of a 3.7 - 4.8 mm/hr. When assuming a 60% eutectic salt reuse rate, over 90% separation efficiency of Cs and Sr is possible, but when increasing the eutectic salt reuse rate to 80%, a separation efficiency of about 82 - 86 % for Cs and Sr was estimated.
유영근 ( Yung-geun Yoo ),정민석 ( Min-seok Joung ),이윤희 ( Youn-hee Lee ),최종완 ( Jong-wan Choi ),김중회 ( Joong-hoi Kim ),백기엽 ( Kee-yoeup Paek ) 대한화장품학회 2004 대한화장품학회지 Vol.30 No.3
본 연구는 식물조직배양 기술을 이용하여 대량으로 배양된 산삼부정근의 추출물에 대한 화장품 원료로서의 응용 가능성을 검토하였다. 본 실험에서 사용된 산삼부정근은 강원도 평창에서 채취한 110년생 천종산삼으로부터 유래된 캘러스에서 부정근을 유도한 후 절취하여 생물 배양기에서 액체 현탁액으로 대량 배양시켰다. 약 5주간의 배양기간을 거쳐 증식된 산삼부정근을 세척하고 건조시킨 후 추출하여 산삼부정근 추출물을 얻었다 조직 배양된 산삼 부정근 추출물의 in vivo에서의 미백 효과를 검증하기 위하여 조직배양된 산삼부정근 추출물을 함유한 제형을 이용한 미백 임상실험을 실시하였다. 그 결과 산삼부정근 추출물을 함유한 제형에서 두드러진 미백효과를 보여주었으며 통계적으로도 유의차(p < 0.0001)를 보여주었다. 그러나 산삼의 주요 성분인 일부 saponin에 대한 tyrosinase 억제 실험 및 B-16 melanoma를 이용한 미백 실험을 실시한 결과 미백효과가 10% 이하로 낮게 나왔으며 인삼 및 홍삼 추출물의 경우에서도 산삼부정근 추출물과 같은 농도에서는 거의 미백 효과가 관찰되지 않았다. 또한 항산화 효과를 알아보기 위한 DPPH 실험에서는 산삼부정근 추출물이 0.05% 농도에서 85% hydroxyl radical 소거능을 보여주었다. This study reviewed the application of an extract from mountain ginseng adventitious roots which had been grown through tissue culture as a cosmetic ingredient. The mountain ginseng adventitious roots were derived from mountain ginseng callus that was induced from mountain ginseng root whose origin is estimated to date back about one hundred years ago. The adventitious roots were separated from callus and grown in a 20 L bioreactor. In order to proliferate the adventitious roots, they were cultured for 5 weeks in bioreactor. Then the harvested mountain ginseng adventitious roots were dried and extracted. For verifying skin whitening effect of an extract from the tissue-cultured mountain ginseng adventitious roots in vivo, we performed the clinical test of it. The research showed the significant skin whitening effect of a mountain ginseng adventitious roots extract and the statistical analysis showed a significant difference (p < 0.0001) between sample (2% mountain ginseng adventitious roots extract) and placebo. But, some saponins showed below 10% inhibitory effect of tyrosinase and melanin synthesis in B-16 melanoma. The extracts of red ginseng and ginseng which were the same concentration as the tissue-cultured mountain ginseng adventitious roots extract's showed little inhibitory effect of tyrosinase and melanin synthesis in B-16 melanoma. In DPPH test, Anti-hydroxyl radical activity of 0.5% the tissue-cultured mountain ginseng adventitious roots extract was 86%.
Lee, Geun Taek,Ha, Yun-Sok,Jung, Yeon Suk,Moon, Sung-Kwon,Kang, Ho Won,Lee, Ok-Jun,Joung, Jae Young,Choi, Yung Hyun,Yun, Seok-Joong,Kim, Wun-Jae,Kim, Isaac Yi Raven Press 2014 Annals of Surgical Oncology Vol. No.
<P>The DHCR24 gene that encodes 3b-hydroxysterol ??24-reductase, an oxidoreductase involved in cholesterol biosynthesis, has been identified as a progression-related gene based on the quantitative real-time PCR (qPCR) gene signature. Here, the functional role of DHCR24 and its clinical relevance in non-muscle-invasive urothelial carcinoma (NMIUC) were investigated.</P>
유영근 ( Yung-geun Yoo ),정민석 ( Min-seok Joung ),최종완 ( Jong-wan Choi ),김중회 ( Joong-hoi Kim ) 대한화장품학회 2005 대한화장품학회지 Vol.31 No.2
본 연구는 한방제제의 구성 약재인 마황이라는 천연한방소재로부터 미백효과가 있는 화장품 원료를 개발하고자 하였다. 본 실험에서 마황추출물의 tyrosinase 억제 효과를 확인하고 마황추출 과정을 세분화하여 methylene chloride 및 물분획물을 얻었으며 이들을 가지고 다시 tyrosinase 억제 실험을 실시하였다. 그 결과 수층부분에서만 0.2% 농도에서 60.6%의 tyrosinase 억제 효과를 보여주었으며 이후 수층부분만을 농축하여 L-DOPA 산화억제 실험 및 B-16 melanoma를 이용한 미백 실험을 실시하였다. 그 결과 마황추출물 0.5% 농도에서 87%의 L-DOPA 산화억제 효과를 보여주었으며, 0.75%에서는 98.8%의 억제효과를 보여주었다. 또한 B-16 melanoma에서는 0.05%에서 70.2%, 0.075%에서는 79.9%의 억제효과를 보여주었다. 그리고 수층부분만을 농축한 마황추출물의 in vivo상에서의 미백 효과를 검증하기 위하여 마황추출물 0.5%를 함유한 제형으로 미백 임상실험을 실시하였다. 그 결과 마황추출물을 함유한 제형에서 10주 경과 후에 육안 및 기기평가 모두에서 미백효과를 보여주었으며 통계적으로도 유의한 차이(p<0.05)를 보여주었다. In this study, we investigated the application of an extract from Ephedra sinica which has been composed of traditional Korean medicine as a whitening ingredient. The extract of Ephedra sinica which was obtained from the mixture of methanol and water (1:1) the inhibitory effect of tyrosinase. Then, Ephedra sinica was extracted by two different solvents. One was water and the other was methylene chloride. Only, the water extract of Ephedra sinica showed the inhibitory effort of tyrosinase; the anti-tyrosinase activity with 0.2% of the water extract was 60.6%. But the extract of Ephedra sinica in methylene chloride fraction showed little inhibitory effect on tyrosinase. The inhibitory effect of the concentrated water extract of Ephedra sinica was tested on L-DOPA auto-oxidation and melanin synthesis in B-16 melanoma. In L-DOPA auto-oxidation, 0.5% of the concentrated water extract showed 87% of inhibition of L-DOPA auto-oxidation and the 0.75% concentrated Ephedra sinica extract in wafer fraction inhibited 98.8% of that. In melanin synthesis of B-16 melanoma, the concentrated water effect of Ephedra sinica inhibited 70.2% or 79.9% of inhibitory effect on that at the concentration of 0.05% or 0.075%, respectively. For verifying the skin whitening effect of the concentrated water extract of Ephedra sinica in vivo, we performed the clinical test of that. The research showed the significant skin whitening effect of a cream containing 0.5% Ephedra sinica extract and the statistical analysis showed a significant difference (p<0.05) between sample (containing 0.5% Ephedra sinica extract) and placebo after 10 weeks.